Signaling mechanisms in growth factor-stimulated cell motility

Stem Cells

Volumn 15, Issue 4, 1997, Pages 259-267

  Anand Apte, Bela ^a   Zetter, Bruce ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Chemotaxis; Platelet derived growth factor; Signaling

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PLATELET DERIVED GROWTH FACTOR;

ACTIN POLYMERIZATION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CHEMOTAXIS; DOWN REGULATION; EPITHELIUM CELL; FIBROBLAST; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0030812439     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150259     Document Type: Review

References (112)

1. Manske M, Bade EG. Growth factor-induced cell migration: biology and methods of analysis. Int Rev Cytol 1994;155:49-96.
2. Rosen EM, Goldberg ID. Protein factors which regulate cell motility. In Vitro Cell Dev Biol 1989;25:1079-1087.
3. Stoker M, Gherardi E. Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta 1991;1072:81-102.
4. Moolenaar WH. Lysophosphatidic acid signaling. Curr Opin Cell Biol 1995;7:203-210.
5. Moolenaar WH. Mitogenic action of lysophosphatidic acid. Adv Cancer Res 1991;57:87-102.
6. Taniguchi S, Tatsuka M, Nakamatsu K et al. High invasiveness associated with augmentation of motility in a fostransferred highly metastatic rat 3Y1 cell line. Cancer Res 1989;49:6738-6744.
7. Feuerstein N, Cooper HL. Studies of the differentiation of promyelocytic cells by phorbol ester. I. Induction of discrete membrane proteins characteristic of monocytes and expression of motility functions in HL-60 cells following differentiation by phorbol ester. Biochim Biophys Acta 1984;781:239-246.
8. Liotta L, Schiffmann E. Tumor autocrine motility factors. Important Adv Oncol 1988;17-30.
9. Seppa H, Grotendorst G, Seppa S et al. Platelet-derived growth factor is chemotactic for fibroblasts. J Cell Biol 1982;92:584-588.
10. Grotendorst GR. Alteration of the chemotactic response of NIH/3T3 cells to PDGF by growth factors, transformation, and tumor promoters. Cell l984;36:279-285.
11. Bornfeldt K. Intracellular signaling in arterial smooth muscle migration versus proliferation. Trends Cardiovasc Med 1996;6:143-151.
12. Welsh M, Mares J, Karlsson T et al. Shb is a ubiquitously expressed Src homology 2 protein. Oncogene 1994;9:19-27.
13. Siegbahn A, Hammacher A, Westermark B et al. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest 1990;85:916-920.
14. Hayashi N, Takehara K, Soma Y. Differential chemotactic responses mediated by platelet-derived growth factor alphaand beta-receptors. Arch Biochem Biophys 1995;322:423-428.
15. Welsh, C. Signal transduction by the PDGF receptors. In: Growth Factor Research. Great Britain: Pergamon Press, 1994;5:37-53.
16. Kundra V, Escobedo JA, Kazlauskas A et al. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 1994;367:474-476.
17. Westermark B, Siegbahn A, Heldin CH et al. B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor proteintyrosine kinase. Proc Natl Acad Sci USA 1990;87:128-132.
18. Pawson T, Gish GD. SH2 and SH3 domains: from structure to function. Cell 1992;71:359-362.
19. Fantl WJ, Escobedo JA, Martin GA et al. Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. Cell 1992;69:413-423.
20. Kim HK, Kim JW, Zilberstein A et al. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell 1991;65:435-441.
21. Kashishian A, Kazlauskas A, Cooper JA. Phosphorylation sites in the PDGF receptor with different specificities for binding GAP and PI3 kinase in vivo. [Published erratum, appears in EMBO J 1992;11:3809.] EMBO J 1992;11:1373-1382.
22. Valius M, Bazenet C, Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxyl terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilo-dalton protein, respectively. Mol Cell Biol 1993;13:133-143.
23. Ronnstrand L, Mori S, Arridsson AK et al. Identification of two C-terminal autophosphorylation sites in the PDGF betareceptor: involvement in the interaction with phospholipase C-gamma. EMBO J 1992;11:3911-3919.
24. Kashishian A, Cooper JA. Phosphorylation sites at the C-terminus of the platelet-derived growth factor receptor bind phospholipase C gamma 1. Mol Biol Cell 1993;4:49-57.
25. Valius M, Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 1993;73:321-334.
26. Berridge MJ, Heslop JP, Irvine RF et al. Inositol triphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor. Biochem J 1984;222:195-201.
27. Nishizuka Y. Turnover of inositol phospholipids and signal transduction. Science 1984;225:1365-1370.
28. Rhee SG, Suh PG, Ryu SH et al. Studies of inositol phospholipid-specific phospholipase C. Science 1989;244:546-550.
29. Devreotes PN, Zigmond SH. Chemotaxis in eukaryotic cells: a focus on leukocytes and Dictyostelium. Annu Rev Cell Biol 1988;4:649-686.
30. Anderson D, Koch CA, Grey L et al. Binding of SH2 domains of phospholipase C gamma 1, GAP, and src to activated growth factor receptors. Science 1990;250:979-982.
31. Bornfeldt KE, Raines EW, Graves LM et al. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann NY Acad Sci 1995;766:416-430.
32. Shariff A, Luna EJ. Diacylglycerol-stimulated formation of actin nucleation sites at plasma membranes. Science 1992;256:245-247.
33. Janmey PA, Stossel TP. Gelsolin-polyphosphoinositide interaction. Full expression of gelsolin-inhibiting function by polyphosphoinositides in vesicular form and inactivation by dilution, aggregation, or masking of the inositol head group. J Biol Chem 1989;264:4825-4831.
34. Stossel TP. On the crawling of animal cells. Science 1993;260:1086-1094.
35. Stossel TP. The machinery of cell crawling. Sci Am 1994;271:54-55.
36. Bacon KB, Camp RD. Interleukin (IL)-8-induced in vitro human lymphocyte migration is inhibited by cholera and pertussis toxins and inhibitors of protein kinase C. Biochem Biophys Res Commun 1990;169:1099-1104.
37. Adelmann-Grill BC, Wach F, Behr J et al. Involvement of protein kinase C in signal transduction during fibroblast chemotaxis to platelet-derived growth factor and a fragment of fibronectin. Eur J Cell Biol 1989;50:128-131.
38. Wennstrom S, Siegbahn A, Yokote K et al. Membrane ruffling and chemotaxis transduced by the PDGF beta-receptor require the binding site for phosphatidylinositol 3́ kinase. Oncogene 1994;9:651-660.
39. Clyman RI, Peters KG, Chen YQ et al. Phospholipase C gamma activation, phosphotidylinositol hydrolysis, and calcium mobilization are not required for FGF receptor-mediated chemotaxis. Cell Adhesion Commun 1994;1:333-342.
40. Grand RJ, Owen D. The biochemistry of ras p21. Biochem J 1991;279:609-631.
41. Trahey M, McCormick F. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 1987;238:542-545.
42. Kazlauskas A, Feng GS, Pawson T et al. The 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase Syp. Proc Natl Acad Sci USA 1993;90:6939-6943.
43. Bornfeldt KE, Graves LM, Raines EW et al. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction. J Cell Biol 1995;130:193-206.
44. Berridge MJ, Dupont G. Spatial and temporal signaling by calcium. Curr Opin Cell Biol 1994;6:267-274.
45. + stores. J Biol Chem 1993;268:6945-6952.
46. Mahoney MG, Slakey LL, Hepler PK et al. Independent modes of propagation of calcium waves in smooth muscle cells. J Cell Sci 1993;104:1101-1107.
47. Fay FS, Gilbert SH, Brundage RA. Calcium signaling during chemotaxis. Ciba Found Symp 1995;188:121-135.
48. +]i and cell shape, polarity, and locomotion by InsP3, DAG, and protein kinase C in newt eosinophils. J Cell Biol 1994;127:489-503.
49. Bornfeldt KE, Raines EW, Nakano T et al. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994;93:1266-1274.
50. + transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase. J Biol Chem 1994;269:9011-9018.
51. Pauly RR, Bilato C, Sollott SJ et al. Role of calcium/calmodulin-dependent protein kinase II in the regulation of vascular smooth muscle cell migration. Circulation 1995;91:1107-1115.
52. Bilato C, Pauly RR, Melillo G et al. Intracellular signaling pathways required for rat vascular smooth muscle cell migration - interactions between basic fibroblast growth factor and platelet-derived growth factor. J Clin Invest 1995;96:1905-1915.
53. +)-and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 1995;376:75-79.
54. de Vries-Smits AM, Burgering BM, Leevers SJ et al. Involvement of p21 ras in activation of extracellular signal-regulated kinase 2. Nature 1992;357:602-604.
55. Cai H, Szeberenyi J, Cooper GM. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol Cell Biol 1990;10:5314-5323.
56. Mulcahy LS, Smith MR, Stacey DW. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 1985;313:241-243.
57. Stacey DW, Kung HF. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein. Nature 1984;310:508-511.
58. Shou C, Farnsworth CL, Neel BG et al. Molecular cloning of cDNAs encoding a guanine-nucleotide-releasing factor for Ras p21. Nature 1992;358:351-354.
59. Kundra V, Anand-Apte B, Feig LA et al. The chemotactic response to PDGF-BB: evidence of a role for ras. J Cell Biol 1995;130:725-731.
60. Fox PL, Sa G, Dobrowolski SF et al. The regulation of endothelial cell motility by p21 ras. Oncogene 1994;9:3519-3526.
61. Sosnowski RG, Feldman S, Feramisco JR. Interference with endogenous ras function inhibits cellular responses to wounding. J Cell Biol 1993;121:113-119.
62. Indolfi C, Avvedimento EV, Rapacciuolo A et al. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nat Med 1995;1:541-545.
63. Hartmann G, Weidner KM, Schwarz H et al. The motility signal of scatter factor hepatocyte growth factor mediated through the receptor tyrosine kinase Met requires intracellular action of Ras. J Biol Chem 1994;269:21936-21939.
64. Takaishi K, Sasaki T, Kato M et al. Involvement of rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene 1994;9:273-279.
65. Ridley AJ, Comoglio PM, Hall A. Regulation of scatter factor/hepatocyte growth factor responses by ras, rac, and rho in MDCK cells. Mol Cell Biol 1995;15:1110-1122.
66. Kundra V, Soker S, Zetter BR. Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB. Oncogene 1994;9:1429-1435.
67. Dent P, Sturgill TW. Activation of (His)(6)-raf-1 in vitro by partially purified plasma membranes from v-Ras-transformed and serum-stimulated fibroblasts. Proc Natl Acad Sci USA 1994;91:9544-9548.
68. Leevers SJ, Paterson HF, Marshall CJ. Requirement for ras in raf activation is overcome by targeting raf to the plasma membrane. Nature 1994;369:411-414.
69. Stokoe D. Activation of raf as a result of recruitment to the plasma membrane. Science 1994;264:1463-1467.
70. Huang W, Alessandrini A, Crews CM et al. Raf-1 forms a stable complex with Mek1 and activates Mek1 by serine phosphorylation. Proc Natl Acad Sci USA 1993;90:10947-10951.
71. Williams NG, Paradis H, Agarwal S et al. Raf-1 and p21v-ras cooperate in the activation of mitogen-activated protein kinase. Proc Natl Acad Sci USA 1993;90:5772-5776.
72. Kyriakis JM, App H, Zhang XF et al. Raf-1 activates MAP kinase-kinase. Nature 1992;358:417-421.
73. Moodie SA, Willumsen BM, Weber MJ et al. Complexes of ras. GTP with raf-1 and mitogen-activated protein kinase kinase. Science 1993;260:1658-1661.
74. Moodie SA, Paris MJ, Kolch W et al. Association of MEK1 with p21(ras)center dot GMPPNP is dependent on B-Raf. Mol Cell Biol 1994;14:7153-7162.
75. Chen P, Xie H, Sekar MC et al. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 1994;127:847-857.
76. Bornfeldt KE, Raines EW, Nakano T et al. Insulin-like growth factor-1 and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994;93:1266-1274.
77. Vojtek AB, Hollenberg SM, Cooper JA. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 1993;74:205-214.
78. Rodriguezviciana P, Warne PH, Dhand R et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994;370:527-532.
79. Boguski MS, McCormick F. Proteins regulating ras and its relatives. Nature 1993;366:643-654.
80. Ridley AJ, Paterson HF, Johnston CL et al. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992;70:401-410.
81. Paterson HF, Self AJ, Garrett MD et al. Microinjection of recombinant p21 rho induces rapid changes in cell morphology. J Cell Biol 1990;111:1001-1007.
82. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
83. Kozma R, Ahmed S, Best A et al. The ras-related protein Cdc42Hs and bradykinin promote formation of peripheral actin microspikes and filopodia in Swiss 3T3 fibroblasts. Mol Cell Biol 1995;15:1942-1952.
84. Hall A. Small GTP-binding proteins and the regulation of the actin cytoskeleton. Annu Rev Cell Biol 1994;10:31-54.
85. Takai Y, Sasaki T, Tanaka K et al. Rho as a regulator of the cytoskeleton. Trends Biochem Sci 1995;20:227-231.
86. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992;70:389-399.
87. Hartwig JH, Bokoch GM, Carpenter CL et al. Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 1995;82:643-653.
88. Aspenstrom P, Lindberg U, Hall A. Two GTPases, cdc42 and rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr Biol 1996;6:70-75.
89. Symons M, Derry JM, Karlak B et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 1996;84:723-734.
90. Kolluri R, Tolias KF, Carpenter CL et al. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase cdc42. Proc Natl Acad Sci USA 1996;93:5615-5618.
91. Symons M. Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci 1996;21:178-181.
92. Qiu RG, Chen J, McCormick F et al. A role for rho in ras transformation. Proc Natl Acad Sci USA 1995;92:11781-11785.
93. Qiu RG, Chen J, Kirn D et al. An essential role for rac in ras transformation. Nature 1995;374:457-459.
94. Khosravifar R, Solski PA, Clark GJ et al. Activation of rac1, rhoA, and mitogen-activated protein kinases is required for ras transformation. Mol Cell Biol 1995;15:6443-6453.
95. Prendergast GC, Khosravi-Far R, Solski PA et al. Critical role of rho in cell transformation by oncogenic ras. Oncogene 1995;10:2289-2296.
96. Zachary I, Rozengurt E. Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 1992;71:891-894.
97. Schaller MD, Parsons JT. Focal adhesion kinase and associated proteins. Curr Opin Cell Biol 1994;6:705-710.
98. Guan JL, Chen HC. Signal transduction in cell-matrix interactions. Int Rev Cytol 1996;168:81-121.
99. Burridge K, Turner CE, Romer LH. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol 1992;119:893-903.
100. Lipfert L, Haimovich B, Schaller MD et al. Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol 1992;119:905-912.
101. Kornberg L, Earp HS, Parsons JT et al. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 1992;267:23439-23442.
102. Hanks SK, Calalb MB, Harper MC et al. Focal adhesion proteintyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 1992;89:8487-8491.
103. Rankin S, Rozengurt E. Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin. J Biol Chem 1994;269:704-710.
104. Abedi H, Dawes KE, Zachary I. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts. J Biol Chem 1995;270:11367-11376.
105. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1994;91:10148-10152.
106. Chen HC, Appeddu PA, Parsons JT et al. Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 1995;270:16995-16999.
107. Matsumoto K, Matsumoto K, Nakamura T et al. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994;269:31807-31813.
108. Ilic D, Kanazawa S, Furuta Y et al. Impairment of mobility in endodermal cells by FAK deficiency. Exp Cell Res 1996;222:298-303.
109. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
110. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983;49:327-333.
111. Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 1993;69:S30-S37.
112. White FC, Carroll SM, Magnet A et al. Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992;71:1490-1500.